We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PHUN:NASDAQPhunware, Inc. Analysis

Data as of 2026-08-16 - not real-time

$2.09

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Phunware, Inc. trades at $2.09, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. RSI sits at 47.9, which reads as neutral, and MACD momentum is bearish. Watch $2.00 as support and $2.24 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is growing at 75.6%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 37.4%, a beta of 1.98 and a maximum drawdown of 47.7%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 2/10 conviction over the longer horizon.

Top Market Events

Company Appoints Industry Veteran and Former FLYR Hospitality Executive Brent McMahan as Senior Director of Sales...Phunware Inc NASDAQ:PHUN, FRA:2RJA has appointed Nick Farrell as senior vice president of sales and added Aaron...Board and Management Reaffirm Confidence in the Company’s 2.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 2.00
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 2.00
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative return on equity of -13.7%
  • Revenue growth of +75.6%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth75.60%
P/E Ratio-4.0
ROE-13.72%
ROA-13.34%
Debt/Equity0.51
P/B Ratio0.5
Op. Cash Flow$-14131000
Free Cash Flow$-13959000
Industry P/E36.5

Technical Analysis

TrendBullish
RSI47.9
Support$2.00
Resistance$2.24
MA 20$2.14
MA 50$2.06
MA 200$2.00
MACDBearish
VolumeIncreasing
Fear & Greed Index95.98

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta1.98
Volatility37.40%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.